Transport Properties of Statins by Organic Anion Transporting Polypeptide 1A2 and Regulation by Transforming Growth Factor-β Signaling in Human Endothelial Cells-Reference-Cited by-同舟云学术

Transport Properties of Statins by Organic Anion Transporting Polypeptide 1A2 and Regulation by Transforming Growth Factor-β Signaling in Human Endothelial Cells

Published:2020-11-09 Issue:2 Volume:376 Page:148-160
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Ronaldson Patrick T.,Brzica Hrvoje,Abdullahi Wazir,Reilly Bianca G.,Davis Thomas P.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference60 articles.

1. Functional Expression of Organic Anion Transporting Polypeptide 1a4 Is Regulated by Transforming Growth Factor-β/Activin Receptor-like Kinase 1 Signaling at the Blood-Brain Barrier

2. Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor;Abdullahi;J Cereb Blood Flow Metab,2017

3. Functional expression of P-glycoprotein and organic anion transporting polypeptides at the blood-brain barrier: understanding transport mechanisms for improved CNS drug delivery?;Abdullahi;AAPS J,2017

4. In Vitro Biliary Clearance of Angiotensin II Receptor Blockers and 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase Inhibitors in Sandwich-Cultured Rat Hepatocytes: Comparison with in Vivo Biliary Clearance

5. Localization of organic anion transporting polypeptide (Oatp) 1a4 and Oatp1c1 at the rat blood-retinal barrier

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic Profiling Reveals Age-Related Changes in Transporter Proteins in the Human Blood-Brain Barrier;2024-07-27

2. The role of oxidative stress in blood–brain barrier disruption during ischemic stroke: Antioxidants in clinical trials;Biochemical Pharmacology;2024-03

3. Atorvastatin-associated myotoxicity: A toxicokinetic review of pharmacogenetic associations to evaluate the feasibility of precision pharmacotherapy;Clinical Biochemistry;2024-02

4. Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics;Expert Opinion on Drug Delivery;2024-01-02

5. CNS Drug Delivery in Stroke: Improving Therapeutic Translation From the Bench to the Bedside;Stroke;2024-01